These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17034119)

  • 61. Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches.
    Xiao HY; Li N; Duan JJ; Jiang B; Lu Z; Ngu K; Tino J; Kopcho LM; Lu H; Chen J; Tebben AJ; Sheriff S; Chang CY; Yanchunas J; Calambur D; Gao M; Shuster DJ; Susulic V; Xie JH; Guarino VR; Wu DR; Gregor KR; Goldstine CB; Hynes J; Macor JE; Salter-Cid L; Burke JR; Shaw PJ; Dhar TGM
    J Med Chem; 2020 Dec; 63(23):15050-15071. PubMed ID: 33261314
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potential antifertility agents. 7. Synthesis and biological activities of 2-,3-, and 6-alkyl-substituted 4-aryl-2-methylcyclohexanecarboxylic acids.
    Crenshaw RR; Luke GM; Jenks TA; Bialy G
    J Med Chem; 1974 Dec; 17(12):1262-8. PubMed ID: 4372352
    [No Abstract]   [Full Text] [Related]  

  • 63. Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure.
    Velcicky J; Wilcken R; Cotesta S; Janser P; Schlapbach A; Wagner T; Piechon P; Villard F; Bouhelal R; Piller F; Harlfinger S; Stringer R; Fehlmann D; Kaupmann K; Littlewood-Evans A; Haffke M; Gommermann N
    J Med Chem; 2020 Sep; 63(17):9856-9875. PubMed ID: 32856916
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hypocholesteremic agents. I. (p-Acetamidophenoxy) acetic acid derivatives.
    SHAPIRO SL; SOLOWAY H; SHAPIRO H; FREEDMAN L
    J Pharm Sci; 1961 Nov; 50():973-4. PubMed ID: 13911317
    [No Abstract]   [Full Text] [Related]  

  • 65. Identifying selective agonists targeting LXRβ from terpene compounds of alismatis rhizoma.
    Lin C; Li J; Wu C; Bao J
    J Mol Model; 2021 Feb; 27(3):91. PubMed ID: 33616795
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of novel liver X receptor activators by structure-based modeling.
    von Grafenstein S; Mihaly-Bison J; Wolber G; Bochkov VN; Liedl KR; Schuster D
    J Chem Inf Model; 2012 May; 52(5):1391-400. PubMed ID: 22489742
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nuclear receptor engineering based on novel structure activity relationships revealed by farnesyl pyrophosphate.
    Goyanka R; Das S; Samuels HH; Cardozo T
    Protein Eng Des Sel; 2010 Nov; 23(11):809-15. PubMed ID: 20817759
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics.
    Huang P; Chandra V; Rastinejad F
    Annu Rev Physiol; 2010; 72():247-72. PubMed ID: 20148675
    [TBL] [Abstract][Full Text] [Related]  

  • 69. LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.
    Quinet EM; Basso MD; Halpern AR; Yates DW; Steffan RJ; Clerin V; Resmini C; Keith JC; Berrodin TJ; Feingold I; Zhong W; Hartman HB; Evans MJ; Gardell SJ; DiBlasio-Smith E; Mounts WM; LaVallie ER; Wrobel J; Nambi P; Vlasuk GP
    J Lipid Res; 2009 Dec; 50(12):2358-70. PubMed ID: 19318684
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists.
    Bennett DJ; Carswell EL; Cooke AJ; Edwards AS; Nimz O
    Curr Med Chem; 2008; 15(2):195-209. PubMed ID: 18220775
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis.
    Hu B; Collini M; Unwalla R; Miller C; Singhaus R; Quinet E; Savio D; Halpern A; Basso M; Keith J; Clerin V; Chen L; Resmini C; Liu QY; Feingold I; Huselton C; Azam F; Farnegardh M; Enroth C; Bonn T; Goos-Nilsson A; Wilhelmsson A; Nambi P; Wrobel J
    J Med Chem; 2006 Oct; 49(21):6151-4. PubMed ID: 17034119
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Further modification on phenyl acetic acid based quinolines as liver X receptor modulators.
    Hu B; Jetter J; Kaufman D; Singhaus R; Bernotas R; Unwalla R; Quinet E; Savio D; Halpern A; Basso M; Keith J; Clerin V; Chen L; Liu QY; Feingold I; Huselton C; Azam F; Goos-Nilsson A; Wilhelmsson A; Nambi P; Wrobel J
    Bioorg Med Chem; 2007 May; 15(10):3321-33. PubMed ID: 17391964
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biarylether amide quinolines as liver X receptor agonists.
    Bernotas RC; Singhaus RR; Kaufman DH; Ullrich J; Fletcher H; Quinet E; Nambi P; Unwalla R; Wilhelmsson A; Goos-Nilsson A; Farnegardh M; Wrobel J
    Bioorg Med Chem; 2009 Feb; 17(4):1663-70. PubMed ID: 19162487
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta.
    Hu B; Unwalla R; Collini M; Quinet E; Feingold I; Goos-Nilsson A; Wihelmsson A; Nambi P; Wrobel J
    Bioorg Med Chem; 2009 May; 17(10):3519-27. PubMed ID: 19394832
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Carboxylic acid based quinolines as liver X receptor modulators that have LXRbeta receptor binding selectivity.
    Hu B; Quinet E; Unwalla R; Collini M; Jetter J; Dooley R; Andraka D; Nogle L; Savio D; Halpern A; Goos-Nilsson A; Wilhelmsson A; Nambi P; Wrobel J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):54-9. PubMed ID: 18023179
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.